More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Recent research suggests a possible increased risk of serious eye conditions, such as non-arteritic anterior ischaemic optic ...

The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor ...

A study has found that prescribing semaglutide in everyday clinical settings led to modest but meaningful improvements in cardiovascular risk alongside a rise in non-drug healthcare costs. The study, ...

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world. Collectively known as GLP-1 agonists, ...

If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...

(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...

Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in ...

Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...

Scientists have found new evidence that Ozempic can slow or even reverse aging — yet another health benefit of the popular ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...